TFF Pharma: The Potential Is Still Very Much Present
While the company added three more big pharma partners, this is not what shareholders prefer to hear as the company already has more than two dozen of these. These partnerships […]
While the company added three more big pharma partners, this is not what shareholders prefer to hear as the company already has more than two dozen of these. These partnerships […]
The shares of TFFP have slumped, most likely as a result of disappointment over an absence of a deal with one of the top mRNA vaccine producers. However, besides a […]
The company’s generic technology provides important benefits and is applicable in a wide range of situations. The company has two dozen shots at goal and is still adding. Cash isn’t […]